This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kumamoto University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations by Yuichi Oike in Heart Failure Treatment
Introduction
Yuichi Oike is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of heart failure. His innovative approach combines advanced genetic techniques with traditional pharmaceutical methods.
Latest Patents
Yuichi Oike holds a patent for a method aimed at treating or preventing heart failure. The patent describes a pharmaceutical composition that includes a DNA sequence encoding RNA with a specific strand sequence derived from angiopoietin-like protein 2 (ANGPTL2) mRNA. This composition can be utilized alongside siRNA and a vector expressing said siRNA, providing a novel approach to combat heart failure. The patent highlights the potential of using an antisense strand sequence that is complementary to the sense strand sequence, all under the control of a promoter, along with a pharmaceutically acceptable carrier. He has 1 patent to his name.
Career Highlights
Yuichi Oike is affiliated with Kumamoto University, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating heart conditions, showcasing his dedication to advancing healthcare.
Collaborations
Yuichi Oike collaborates with esteemed colleagues such as Tian Zhe and Haruki Horiguchi. Their combined expertise contributes to the development of groundbreaking treatments and enhances the research environment at Kumamoto University.
Conclusion
Yuichi Oike's contributions to the treatment of heart failure through innovative pharmaceutical compositions demonstrate his commitment to improving patient outcomes. His work exemplifies the intersection of research and practical application in medicine.